Ki Young Kim

Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion

Jeong Hyun Lee, So Youn Park, Yung Woo Shin et al. · Brain Research · 2006 · 70 citations

Cerebral Vascular Regulation, Chronic Cerebral Hypoperfusion, Neurophysiology +14

Differential anti-proliferative actions of peroxisome proliferator-activated receptor-γ agonists in MCF-7 breast cancer cells

Ki Young Kim, Sung Soo Kim, Hyae Gyeong Cheon · Biochemical Pharmacology · 2006 · 64 citations

Breast Oncology, Medicine, Tumor Immunity +11

Randomized Comparison of Cilostazol vs Clopidogrel After Drug-Eluting Stenting in Diabetic Patients CIilostazol for Diabetic Patients in Drug-Eluting Stent (CIDES) Trial

Youngkeun Ahn, Myung Ho Jeong, Jong Weon Jeong et al. · Circulation Journal · 2007 · 56 citations · Full text

Synthesis and biological evaluation of aminobenzimidazole derivatives with a phenylcyclohexyl acetic acid group as anti-obesity and anti-diabetic agents

Hyun Jung Kwak, Yu Mi Pyun, Ji Young Kim et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 43 citations · Full text

Anti-diabetic Agents, Biochemistry, Pharmacological Agent +4

Cilostazol Prevents Tumor Necrosis Factor-α-Induced Cell Death by Suppression of Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation and Activation of Akt/Cyclic AMP Response Element-Binding Protein Phosphorylation

Ki Whan Hong, Ki Young Kim, Hwa Kyoung Shin et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 39 citations